New CDC Data Reveal Less Than a Third of People Diagnosed with Hepatitis C Receive Timely Treatment

August 9, 2022 – Large gaps in hep C treatment persist nearly a decade after a highly effective cure for this deadly infection was approved

A new CDC Vital Signs report finds that too few people diagnosed with hepatitis C are being treated, even though hepatitis C is largely curable. According to CDC’s estimates, overall, less than 1 in 3 people with health insurance receive direct-acting antiviral treatment for hepatitis C within a year of diagnosis. Treatment is even lower among people who are Medicaid recipients, those living in states with Medicaid treatment restrictions, and among adults under the age of 40.

TO CONTINUE: https://www.cdc.gov/nchhstp/newsroom/2022/2022-Hep-C-Vital-Signs.html?ACSTrackingID=USCDC_243-DM82556&ACSTrackingLabel=New%20CD​